Catherine Ramsey
Stock Analyst at Baird
(3.17)
# 1,234
Out of 4,843 analysts
49
Total ratings
42.11%
Success rate
4.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Maintains: Outperform | $355 → $374 | $349.24 | +7.09% | 10 | May 7, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $29.30 | +50.17% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $90.42 | +38.24% | 5 | Apr 29, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $82.24 | +9.44% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $157.73 | +19.19% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $15.97 | +131.68% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $402.82 | +65.09% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $111.92 | +42.96% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $56.28 | +33.26% | 1 | Aug 3, 2022 |
Waters
May 7, 2025
Maintains: Outperform
Price Target: $355 → $374
Current: $349.24
Upside: +7.09%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $29.30
Upside: +50.17%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $90.42
Upside: +38.24%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $82.24
Upside: +9.44%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $157.73
Upside: +19.19%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $15.97
Upside: +131.68%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $402.82
Upside: +65.09%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $111.92
Upside: +42.96%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $56.28
Upside: +33.26%